Recent Quotes (30 days)

You have no recent quotes
chg | %

RepliCel Life Sciences Inc  

(Public, CNSX:RP)   Watch this stock  
Find more results for RP
Dec 11 - Close
CNSX real-time data - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.55
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS 0.00
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -439.93% -380.67%
Return on average equity -626.73% -1412.77%
Employees 4 -
CDP Score - -


570 Granville St Suite 900
+1-604-2488693 (Phone)
+1-604-2488690 (Fax)

Website links


RepliCel Life Sciences Inc. is a regenerative medicine company focused on developing autologous cell therapies that treat functional cellular deficits. The Company's product pipeline includes RCT-01-Tendon Repair, RCS-01-Skin Rejuvenation, RCH-01-Hair Regeneration and RCI-02-Dermal Injector. RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from the hair follicle sheath to treat chronic tendinosis caused by acute and chronic tensile overuse. RCH-01 also utilizes dermal sheath cup cells isolated from the hair follicle to treat androgenetic alopecia. RCI-02 is a dermal injector designed to control intradermal (dermis), subcutaneous (fat) or intramuscular injections. It is designed to support the injection of RCH-01 and RCS-01 cell therapy products. The injector has applications for dermatological procedures requiring injections of specific volumes of material at specific depths, including cellular products, fillers and collagen injections.

Officers and directors

David M. Hall Chairman of the Board
Age: 60
R. Lee Buckler President, Chief Executive Officer, Director
Thomas A. Kordyback C.A. Chief Financial Officer
Age: 62
Brooke Hurford Director - Finance, Corporate Secretary
Kevin McElwee Ph.D. Chief Scientific Officer
Age: 43
Gemma Fetterley Vice President - Finance, Treasurer
Age: 35
Darrell Panich Vice President - Clinical Affairs
Age: 42
Rolf Hoffmann M.D. Chief Medical Officer
Age: 51
John Challis Director
Age: 66
Peter K. Jensen Director
Age: 63